Cargando…

Speech Illusions in People at Clinical High Risk for Psychosis Linked to Clinical Outcome

BACKGROUND AND HYPOTHESIS: Around 20% of people at clinical high risk (CHR) for psychosis later develop a psychotic disorder, but it is difficult to predict who this will be. We assessed the incidence of hearing speech (termed speech illusions [SIs]) in noise in CHR participants and examined whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hird, Emily J, Ohmuro, Noriyuki, Allen, Paul, Moseley, Peter, Kempton, Matthew J, Modinos, Gemma, Sachs, Gabriele, van der Gaag, Mark, de Haan, Lieuwe, Gadelha, Ary, Bressan, Rodrigo, Barrantes-Vidal, Neus, Ruhrmann, Stephan, Catalan, Ana, McGuire, Philip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10016413/ https://www.ncbi.nlm.nih.gov/pubmed/36516396 http://dx.doi.org/10.1093/schbul/sbac163

Ejemplares similares

Impact of adverse childhood experiences on educational achievements in young people at clinical high risk of developing psychosis
por: Tognin, Stefania, et al.
Publicado: (2023)

S175. CLINICAL OUTCOMES IN PEOPLE AT HIGH RISK FOR PSYCHOSIS RELATED TO INTERACTIONS BETWEEN POLYGENIC RISK SCORES AND CHILDHOOD ADVERSITY
por: Richter, Anja, et al.
Publicado: (2020)

Relationship between jumping to conclusions and clinical outcomes in people at clinical high-risk for psychosis
por: Catalan, Ana, et al.
Publicado: (2022)

Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2021)

The Relationship Between Grey Matter Volume and Clinical and Functional Outcomes in People at Clinical High Risk for Psychosis
por: Tognin, Stefania, et al.
Publicado: (2022)

Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis
por: Modinos, Gemma, et al.
Publicado: (2019)

Differential trajectories of tobacco smoking in people at ultra-high risk for psychosis: Associations with clinical outcomes
por: Schirmbeck, Frederike, et al.
Publicado: (2022)

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
por: Pollak, Thomas A., et al.
Publicado: (2020)

Impact of Comorbid Affective Disorders on Longitudinal Clinical Outcomes in Individuals at Ultra-high Risk for Psychosis
por: Schirmbeck, Frederike, et al.
Publicado: (2021)

Sex differences in cognitive functioning of patients at-risk for psychosis and healthy controls: Results from the European Gene–Environment Interactions study
por: Menghini-Müller, Stephanie, et al.
Publicado: (2020)

Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective
por: Ong, Hui Lin, et al.
Publicado: (2021)

T21. DEVELOPMENT OF PROTEOMIC PREDICTION MODELS FOR OUTCOMES IN THE CLINICAL HIGH RISK STATE AND PSYCHOTIC EXPERIENCES IN ADOLESCENCE: MACHINE LEARNING ANALYSES IN TWO NESTED CASE-CONTROL STUDIES
por: Mongan, David, et al.
Publicado: (2020)

Impact of smoking Behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study
por: van der Heijden, Heleen S., et al.
Publicado: (2021)

Impact of smoking behavior on cognitive functioning in persons at risk for psychosis and healthy controls: A longitudinal study – CORRIGENDUM
por: van der Heijden, Heleen S., et al.
Publicado: (2022)

Momentary Manifestations of Negative Symptoms as Predictors of Clinical Outcomes in People at High Risk for Psychosis: Experience Sampling Study
por: Paetzold, Isabell, et al.
Publicado: (2021)

Neural correlates of emotional processing in psychosis risk and onset – A systematic review and meta-analysis of fMRI studies
por: Lukow, P.B., et al.
Publicado: (2021)

M163. GLUTAMATE METABOLITES ARE ASSOCIATED WITH ALTERED HIPPOCAMPAL ACTIVATION BUT NOT HIPPOCAMPAL-STRIATAL CONNECTIVITY IN SUBJECTS WITH A CLINICAL HIGH RISK FOR PSYCHOSIS
por: Hird, Emily, et al.
Publicado: (2020)

Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

Identifying Electroencephalography Biomarkers in Individuals at Clinical High Risk for Psychosis in an International Multi-Site Study
por: Kerins, Sarah, et al.
Publicado: (2022)

Correction: Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
por: Allen, Paul, et al.
Publicado: (2021)

Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence
por: Mongan, David, et al.
Publicado: (2021)

How can neuroimaging facilitate the diagnosis and stratification of patients with psychosis?
por: Kempton, Matthew J., et al.
Publicado: (2015)

Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice
por: Tognin, Stefania, et al.
Publicado: (2020)

Meta-analysis of longitudinal neurocognitive performance in people at clinical high-risk for psychosis
por: Hedges, Emily P., et al.
Publicado: (2022)

Acceptability of cannabidiol in patients with psychosis
por: Chesney, Edward, et al.
Publicado: (2022)

Effects of Benzodiazepine Exposure on Real-World Clinical Outcomes in Individuals at Clinical High-Risk for Psychosis
por: Livingston, Nicholas R., et al.
Publicado: (2023)

Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study
por: Paetzold, I., et al.
Publicado: (2021)

Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022)

S150. EMOTIONAL BEHAVIOUR IN HIGH-RISK AND FIRST-EPISODE PSYCHOSIS
por: Falkenberg, Irina, et al.
Publicado: (2020)

The Placebo Effect in Psychosis: Why It Matters and How to Measure It
por: Hird, Emily J., et al.
Publicado: (2023)

Correction: Hippocampal circuit dysfunction in psychosis
por: Knight, Samuel, et al.
Publicado: (2022)

T133. NEURAL CORRELATES OF EMOTIONAL PROCESSING IN PSYCHOSIS RISK AND ONSET – A SYSTEMATIC REVIEW AND META-ANALYSIS OF FMRI STUDIES
por: Lukow, Paulina, et al.
Publicado: (2020)

Prevalence of Neuroradiological Abnormalities in First-Episode Psychosis: A Systematic Review and Meta-analysis
por: Blackman, Graham, et al.
Publicado: (2023)

M113. THE RELATIONSHIP BETWEEN ATTACHMENT STYLES AND CLINICAL PRESENTATION IN EARLY PSYCHOSIS PATIENTS
por: Gizdic, Alena, et al.
Publicado: (2020)

F126. PATHWAYS FROM SPEECH ILLUSIONS TO PSYCHOTIC SYMPTOMS IN SUBJECTS AT ULTRA-HIGH RISK FOR PSYCHOSIS: COMBINING AN EXPERIMENTAL PARADIGM OF ABERRANT EXPERIENCES WITH NETWORK ANALYSIS
por: Isvoranu, Adela-Maria, et al.
Publicado: (2018)

Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
por: Oliver, Dominic, et al.
Publicado: (2023)

Pattern classification of brain activation during emotional processing in subclinical depression: psychosis proneness as potential confounding factor
por: Modinos, Gemma, et al.
Publicado: (2013)

Integrated metastate functional connectivity networks predict change in symptom severity in clinical high risk for psychosis
por: Gifford, George, et al.
Publicado: (2020)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1m4krd22vrrib6tdi58sdorccm